nodes	percent_of_prediction	percent_of_DWPC	metapath
Emtricitabine—Lamivudine—acquired immunodeficiency syndrome	0.26	1	CrCtD
Emtricitabine—DCK—Lamivudine—acquired immunodeficiency syndrome	0.0939	1	CbGbCtD
Emtricitabine—Zalcitabine—Didanosine—acquired immunodeficiency syndrome	0.0633	0.363	CrCrCtD
Emtricitabine—Nucleoside Reverse Transcriptase Inhibitors—Zidovudine—acquired immunodeficiency syndrome	0.0591	0.145	CiPCiCtD
Emtricitabine—Nucleoside Reverse Transcriptase Inhibitors—Didanosine—acquired immunodeficiency syndrome	0.0591	0.145	CiPCiCtD
Emtricitabine—Nucleoside Reverse Transcriptase Inhibitors—Stavudine—acquired immunodeficiency syndrome	0.0591	0.145	CiPCiCtD
Emtricitabine—Nucleoside Reverse Transcriptase Inhibitors—Abacavir—acquired immunodeficiency syndrome	0.0591	0.145	CiPCiCtD
Emtricitabine—Nucleoside Reverse Transcriptase Inhibitors—Lamivudine—acquired immunodeficiency syndrome	0.0448	0.11	CiPCiCtD
Emtricitabine—Zalcitabine—Lamivudine—acquired immunodeficiency syndrome	0.0333	0.191	CrCrCtD
Emtricitabine—Floxuridine—Stavudine—acquired immunodeficiency syndrome	0.0317	0.182	CrCrCtD
Emtricitabine—Floxuridine—Zidovudine—acquired immunodeficiency syndrome	0.0317	0.182	CrCrCtD
Emtricitabine—Nucleoside Analog—Abacavir—acquired immunodeficiency syndrome	0.0266	0.0652	CiPCiCtD
Emtricitabine—Nucleoside Analog—Zidovudine—acquired immunodeficiency syndrome	0.0266	0.0652	CiPCiCtD
Emtricitabine—Nucleoside Analog—Stavudine—acquired immunodeficiency syndrome	0.0266	0.0652	CiPCiCtD
Emtricitabine—Nucleoside Analog—Didanosine—acquired immunodeficiency syndrome	0.0266	0.0652	CiPCiCtD
Emtricitabine—Nucleoside Analog—Lamivudine—acquired immunodeficiency syndrome	0.0201	0.0494	CiPCiCtD
Emtricitabine—Decitabine—Lamivudine—acquired immunodeficiency syndrome	0.0145	0.0829	CrCrCtD
Emtricitabine—DCK—retina—acquired immunodeficiency syndrome	0.000362	0.134	CbGeAlD
Emtricitabine—DCK—lymphoid tissue—acquired immunodeficiency syndrome	0.000257	0.0952	CbGeAlD
Emtricitabine—DCK—digestive system—acquired immunodeficiency syndrome	0.000254	0.0941	CbGeAlD
Emtricitabine—DCK—blood—acquired immunodeficiency syndrome	0.000242	0.0896	CbGeAlD
Emtricitabine—DCK—bone marrow—acquired immunodeficiency syndrome	0.000234	0.0867	CbGeAlD
Emtricitabine—DCK—spinal cord—acquired immunodeficiency syndrome	0.000233	0.0863	CbGeAlD
Emtricitabine—DCK—vagina—acquired immunodeficiency syndrome	0.000224	0.0831	CbGeAlD
Emtricitabine—DCK—lung—acquired immunodeficiency syndrome	0.000212	0.0786	CbGeAlD
Emtricitabine—DCK—nervous system—acquired immunodeficiency syndrome	0.000197	0.0728	CbGeAlD
Emtricitabine—DCK—central nervous system—acquired immunodeficiency syndrome	0.000189	0.07	CbGeAlD
Emtricitabine—DCK—brain—acquired immunodeficiency syndrome	0.00015	0.0556	CbGeAlD
Emtricitabine—DCK—lymph node—acquired immunodeficiency syndrome	0.000145	0.0537	CbGeAlD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	1.82e-05	0.000297	CcSEcCtD
Emtricitabine—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	1.82e-05	0.000297	CcSEcCtD
Emtricitabine—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	1.82e-05	0.000297	CcSEcCtD
Emtricitabine—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	1.82e-05	0.000296	CcSEcCtD
Emtricitabine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	1.82e-05	0.000296	CcSEcCtD
Emtricitabine—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	1.81e-05	0.000295	CcSEcCtD
Emtricitabine—Insomnia—Zidovudine—acquired immunodeficiency syndrome	1.81e-05	0.000295	CcSEcCtD
Emtricitabine—Skin disorder—Indinavir—acquired immunodeficiency syndrome	1.81e-05	0.000295	CcSEcCtD
Emtricitabine—Urticaria—Abacavir—acquired immunodeficiency syndrome	1.8e-05	0.000294	CcSEcCtD
Emtricitabine—Cough—Delavirdine—acquired immunodeficiency syndrome	1.8e-05	0.000293	CcSEcCtD
Emtricitabine—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	1.8e-05	0.000293	CcSEcCtD
Emtricitabine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	1.79e-05	0.000292	CcSEcCtD
Emtricitabine—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	1.79e-05	0.000292	CcSEcCtD
Emtricitabine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	1.79e-05	0.000291	CcSEcCtD
Emtricitabine—Back pain—Saquinavir—acquired immunodeficiency syndrome	1.78e-05	0.000289	CcSEcCtD
Emtricitabine—Anaemia—Ritonavir—acquired immunodeficiency syndrome	1.76e-05	0.000287	CcSEcCtD
Emtricitabine—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	1.76e-05	0.000287	CcSEcCtD
Emtricitabine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	1.76e-05	0.000286	CcSEcCtD
Emtricitabine—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	1.76e-05	0.000286	CcSEcCtD
Emtricitabine—Myalgia—Delavirdine—acquired immunodeficiency syndrome	1.76e-05	0.000286	CcSEcCtD
Emtricitabine—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	1.75e-05	0.000285	CcSEcCtD
Emtricitabine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	1.75e-05	0.000285	CcSEcCtD
Emtricitabine—Nausea—Amprenavir—acquired immunodeficiency syndrome	1.73e-05	0.000282	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	1.73e-05	0.000282	CcSEcCtD
Emtricitabine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	1.73e-05	0.000281	CcSEcCtD
Emtricitabine—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	1.73e-05	0.000281	CcSEcCtD
Emtricitabine—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	1.72e-05	0.000281	CcSEcCtD
Emtricitabine—Pain—Zidovudine—acquired immunodeficiency syndrome	1.71e-05	0.000279	CcSEcCtD
Emtricitabine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	1.71e-05	0.000279	CcSEcCtD
Emtricitabine—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	1.71e-05	0.000278	CcSEcCtD
Emtricitabine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	1.7e-05	0.000277	CcSEcCtD
Emtricitabine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	1.7e-05	0.000276	CcSEcCtD
Emtricitabine—Anaemia—Saquinavir—acquired immunodeficiency syndrome	1.7e-05	0.000276	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	1.7e-05	0.000276	CcSEcCtD
Emtricitabine—Back pain—Lamivudine—acquired immunodeficiency syndrome	1.69e-05	0.000276	CcSEcCtD
Emtricitabine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	1.69e-05	0.000275	CcSEcCtD
Emtricitabine—Vomiting—Didanosine—acquired immunodeficiency syndrome	1.69e-05	0.000275	CcSEcCtD
Emtricitabine—Insomnia—Indinavir—acquired immunodeficiency syndrome	1.68e-05	0.000274	CcSEcCtD
Emtricitabine—Rash—Didanosine—acquired immunodeficiency syndrome	1.67e-05	0.000273	CcSEcCtD
Emtricitabine—Infection—Delavirdine—acquired immunodeficiency syndrome	1.67e-05	0.000272	CcSEcCtD
Emtricitabine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	1.67e-05	0.000272	CcSEcCtD
Emtricitabine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	1.67e-05	0.000272	CcSEcCtD
Emtricitabine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	1.67e-05	0.000272	CcSEcCtD
Emtricitabine—Cough—Ritonavir—acquired immunodeficiency syndrome	1.66e-05	0.000271	CcSEcCtD
Emtricitabine—Headache—Didanosine—acquired immunodeficiency syndrome	1.66e-05	0.000271	CcSEcCtD
Emtricitabine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	1.66e-05	0.00027	CcSEcCtD
Emtricitabine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	1.66e-05	0.00027	CcSEcCtD
Emtricitabine—Asthenia—Stavudine—acquired immunodeficiency syndrome	1.65e-05	0.000269	CcSEcCtD
Emtricitabine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	1.65e-05	0.000268	CcSEcCtD
Emtricitabine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	1.64e-05	0.000267	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	1.64e-05	0.000267	CcSEcCtD
Emtricitabine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	1.64e-05	0.000266	CcSEcCtD
Emtricitabine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	1.64e-05	0.000266	CcSEcCtD
Emtricitabine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	1.63e-05	0.000266	CcSEcCtD
Emtricitabine—Pruritus—Stavudine—acquired immunodeficiency syndrome	1.63e-05	0.000265	CcSEcCtD
Emtricitabine—Asthenia—Abacavir—acquired immunodeficiency syndrome	1.63e-05	0.000265	CcSEcCtD
Emtricitabine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	1.62e-05	0.000264	CcSEcCtD
Emtricitabine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	1.62e-05	0.000264	CcSEcCtD
Emtricitabine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	1.62e-05	0.000264	CcSEcCtD
Emtricitabine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	1.62e-05	0.000264	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	1.61e-05	0.000263	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	1.61e-05	0.000262	CcSEcCtD
Emtricitabine—Pruritus—Abacavir—acquired immunodeficiency syndrome	1.61e-05	0.000262	CcSEcCtD
Emtricitabine—Fatigue—Indinavir—acquired immunodeficiency syndrome	1.61e-05	0.000261	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	1.6e-05	0.000261	CcSEcCtD
Emtricitabine—Cough—Saquinavir—acquired immunodeficiency syndrome	1.6e-05	0.000261	CcSEcCtD
Emtricitabine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	1.6e-05	0.000261	CcSEcCtD
Emtricitabine—Pain—Indinavir—acquired immunodeficiency syndrome	1.59e-05	0.000259	CcSEcCtD
Emtricitabine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	1.59e-05	0.000259	CcSEcCtD
Emtricitabine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	1.59e-05	0.000259	CcSEcCtD
Emtricitabine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	1.58e-05	0.000258	CcSEcCtD
Emtricitabine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	1.58e-05	0.000258	CcSEcCtD
Emtricitabine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	1.58e-05	0.000258	CcSEcCtD
Emtricitabine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	1.58e-05	0.000257	CcSEcCtD
Emtricitabine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	1.58e-05	0.000257	CcSEcCtD
Emtricitabine—Nausea—Didanosine—acquired immunodeficiency syndrome	1.58e-05	0.000257	CcSEcCtD
Emtricitabine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	1.57e-05	0.000255	CcSEcCtD
Emtricitabine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	1.56e-05	0.000255	CcSEcCtD
Emtricitabine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	1.56e-05	0.000255	CcSEcCtD
Emtricitabine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	1.56e-05	0.000254	CcSEcCtD
Emtricitabine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	1.55e-05	0.000253	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	1.55e-05	0.000253	CcSEcCtD
Emtricitabine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	1.55e-05	0.000252	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	1.53e-05	0.00025	CcSEcCtD
Emtricitabine—Cough—Lamivudine—acquired immunodeficiency syndrome	1.53e-05	0.000249	CcSEcCtD
Emtricitabine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	1.53e-05	0.000249	CcSEcCtD
Emtricitabine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	1.53e-05	0.000249	CcSEcCtD
Emtricitabine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	1.52e-05	0.000248	CcSEcCtD
Emtricitabine—Dizziness—Stavudine—acquired immunodeficiency syndrome	1.52e-05	0.000248	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	1.52e-05	0.000248	CcSEcCtD
Emtricitabine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	1.52e-05	0.000248	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	1.52e-05	0.000247	CcSEcCtD
Emtricitabine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	1.52e-05	0.000247	CcSEcCtD
Emtricitabine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	1.52e-05	0.000247	CcSEcCtD
Emtricitabine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	1.51e-05	0.000246	CcSEcCtD
Emtricitabine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	1.51e-05	0.000246	CcSEcCtD
Emtricitabine—Pain—Efavirenz—acquired immunodeficiency syndrome	1.5e-05	0.000245	CcSEcCtD
Emtricitabine—Rash—Nevirapine—acquired immunodeficiency syndrome	1.5e-05	0.000245	CcSEcCtD
Emtricitabine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	1.5e-05	0.000245	CcSEcCtD
Emtricitabine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	1.5e-05	0.000244	CcSEcCtD
Emtricitabine—Dizziness—Abacavir—acquired immunodeficiency syndrome	1.5e-05	0.000244	CcSEcCtD
Emtricitabine—Headache—Nevirapine—acquired immunodeficiency syndrome	1.5e-05	0.000243	CcSEcCtD
Emtricitabine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	1.49e-05	0.000243	CcSEcCtD
Emtricitabine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	1.49e-05	0.000243	CcSEcCtD
Emtricitabine—Infection—Saquinavir—acquired immunodeficiency syndrome	1.49e-05	0.000242	CcSEcCtD
Emtricitabine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	1.49e-05	0.000242	CcSEcCtD
Emtricitabine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	1.48e-05	0.000241	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	1.48e-05	0.000241	CcSEcCtD
Emtricitabine—Urticaria—Indinavir—acquired immunodeficiency syndrome	1.48e-05	0.000241	CcSEcCtD
Emtricitabine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	1.47e-05	0.00024	CcSEcCtD
Emtricitabine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	1.47e-05	0.00024	CcSEcCtD
Emtricitabine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	1.47e-05	0.000239	CcSEcCtD
Emtricitabine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	1.47e-05	0.000239	CcSEcCtD
Emtricitabine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	1.47e-05	0.000239	CcSEcCtD
Emtricitabine—Vomiting—Stavudine—acquired immunodeficiency syndrome	1.47e-05	0.000239	CcSEcCtD
Emtricitabine—Rash—Nelfinavir—acquired immunodeficiency syndrome	1.46e-05	0.000237	CcSEcCtD
Emtricitabine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	1.46e-05	0.000237	CcSEcCtD
Emtricitabine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	1.46e-05	0.000237	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	1.45e-05	0.000237	CcSEcCtD
Emtricitabine—Rash—Stavudine—acquired immunodeficiency syndrome	1.45e-05	0.000237	CcSEcCtD
Emtricitabine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	1.45e-05	0.000236	CcSEcCtD
Emtricitabine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	1.45e-05	0.000236	CcSEcCtD
Emtricitabine—Headache—Nelfinavir—acquired immunodeficiency syndrome	1.45e-05	0.000236	CcSEcCtD
Emtricitabine—Headache—Stavudine—acquired immunodeficiency syndrome	1.44e-05	0.000235	CcSEcCtD
Emtricitabine—Vomiting—Abacavir—acquired immunodeficiency syndrome	1.44e-05	0.000235	CcSEcCtD
Emtricitabine—Pain—Delavirdine—acquired immunodeficiency syndrome	1.44e-05	0.000234	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	1.44e-05	0.000234	CcSEcCtD
Emtricitabine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	1.44e-05	0.000234	CcSEcCtD
Emtricitabine—Rash—Abacavir—acquired immunodeficiency syndrome	1.43e-05	0.000233	CcSEcCtD
Emtricitabine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	1.43e-05	0.000233	CcSEcCtD
Emtricitabine—Headache—Abacavir—acquired immunodeficiency syndrome	1.42e-05	0.000232	CcSEcCtD
Emtricitabine—Infection—Lamivudine—acquired immunodeficiency syndrome	1.42e-05	0.000231	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	1.42e-05	0.000231	CcSEcCtD
Emtricitabine—Nausea—Nevirapine—acquired immunodeficiency syndrome	1.42e-05	0.000231	CcSEcCtD
Emtricitabine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	1.42e-05	0.000231	CcSEcCtD
Emtricitabine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	1.41e-05	0.000229	CcSEcCtD
Emtricitabine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	1.4e-05	0.000228	CcSEcCtD
Emtricitabine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	1.4e-05	0.000228	CcSEcCtD
Emtricitabine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	1.4e-05	0.000228	CcSEcCtD
Emtricitabine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	1.4e-05	0.000228	CcSEcCtD
Emtricitabine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	1.39e-05	0.000227	CcSEcCtD
Emtricitabine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	1.39e-05	0.000227	CcSEcCtD
Emtricitabine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	1.39e-05	0.000226	CcSEcCtD
Emtricitabine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	1.39e-05	0.000226	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	1.38e-05	0.000224	CcSEcCtD
Emtricitabine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	1.37e-05	0.000224	CcSEcCtD
Emtricitabine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	1.37e-05	0.000223	CcSEcCtD
Emtricitabine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	1.37e-05	0.000223	CcSEcCtD
Emtricitabine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	1.37e-05	0.000223	CcSEcCtD
Emtricitabine—Nausea—Stavudine—acquired immunodeficiency syndrome	1.37e-05	0.000223	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	1.37e-05	0.000222	CcSEcCtD
Emtricitabine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	1.36e-05	0.000221	CcSEcCtD
Emtricitabine—Nausea—Abacavir—acquired immunodeficiency syndrome	1.35e-05	0.00022	CcSEcCtD
Emtricitabine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	1.35e-05	0.000219	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	1.34e-05	0.000219	CcSEcCtD
Emtricitabine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	1.34e-05	0.000219	CcSEcCtD
Emtricitabine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	1.34e-05	0.000218	CcSEcCtD
Emtricitabine—Asthenia—Indinavir—acquired immunodeficiency syndrome	1.34e-05	0.000218	CcSEcCtD
Emtricitabine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	1.34e-05	0.000218	CcSEcCtD
Emtricitabine—Pain—Ritonavir—acquired immunodeficiency syndrome	1.33e-05	0.000217	CcSEcCtD
Emtricitabine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	1.33e-05	0.000217	CcSEcCtD
Emtricitabine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	1.33e-05	0.000217	CcSEcCtD
Emtricitabine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	1.32e-05	0.000216	CcSEcCtD
Emtricitabine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	1.32e-05	0.000215	CcSEcCtD
Emtricitabine—Pruritus—Indinavir—acquired immunodeficiency syndrome	1.32e-05	0.000215	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	1.3e-05	0.000212	CcSEcCtD
Emtricitabine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	1.3e-05	0.000211	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	1.29e-05	0.000211	CcSEcCtD
Emtricitabine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	1.29e-05	0.000211	CcSEcCtD
Emtricitabine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	1.29e-05	0.00021	CcSEcCtD
Emtricitabine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	1.28e-05	0.000209	CcSEcCtD
Emtricitabine—Pain—Saquinavir—acquired immunodeficiency syndrome	1.28e-05	0.000209	CcSEcCtD
Emtricitabine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	1.27e-05	0.000208	CcSEcCtD
Emtricitabine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	1.27e-05	0.000208	CcSEcCtD
Emtricitabine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	1.27e-05	0.000207	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	1.27e-05	0.000207	CcSEcCtD
Emtricitabine—Rash—Zidovudine—acquired immunodeficiency syndrome	1.26e-05	0.000206	CcSEcCtD
Emtricitabine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	1.26e-05	0.000206	CcSEcCtD
Emtricitabine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	1.26e-05	0.000205	CcSEcCtD
Emtricitabine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	1.26e-05	0.000205	CcSEcCtD
Emtricitabine—Headache—Zidovudine—acquired immunodeficiency syndrome	1.25e-05	0.000204	CcSEcCtD
Emtricitabine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	1.25e-05	0.000203	CcSEcCtD
Emtricitabine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	1.24e-05	0.000202	CcSEcCtD
Emtricitabine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	1.24e-05	0.000201	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	1.23e-05	0.000201	CcSEcCtD
Emtricitabine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	1.23e-05	0.000201	CcSEcCtD
Emtricitabine—Dizziness—Indinavir—acquired immunodeficiency syndrome	1.23e-05	0.000201	CcSEcCtD
Emtricitabine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	1.23e-05	0.0002	CcSEcCtD
Emtricitabine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	1.23e-05	0.0002	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	1.23e-05	0.0002	CcSEcCtD
Emtricitabine—Pain—Lamivudine—acquired immunodeficiency syndrome	1.22e-05	0.000199	CcSEcCtD
Emtricitabine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	1.21e-05	0.000197	CcSEcCtD
Emtricitabine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	1.2e-05	0.000196	CcSEcCtD
Emtricitabine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	1.19e-05	0.000194	CcSEcCtD
Emtricitabine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	1.19e-05	0.000194	CcSEcCtD
Emtricitabine—Nausea—Zidovudine—acquired immunodeficiency syndrome	1.19e-05	0.000194	CcSEcCtD
Emtricitabine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	1.18e-05	0.000193	CcSEcCtD
Emtricitabine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	1.18e-05	0.000193	CcSEcCtD
Emtricitabine—Vomiting—Indinavir—acquired immunodeficiency syndrome	1.18e-05	0.000193	CcSEcCtD
Emtricitabine—Rash—Indinavir—acquired immunodeficiency syndrome	1.17e-05	0.000191	CcSEcCtD
Emtricitabine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	1.17e-05	0.000191	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	1.17e-05	0.00019	CcSEcCtD
Emtricitabine—Headache—Indinavir—acquired immunodeficiency syndrome	1.17e-05	0.00019	CcSEcCtD
Emtricitabine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	1.16e-05	0.00019	CcSEcCtD
Emtricitabine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	1.15e-05	0.000188	CcSEcCtD
Emtricitabine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	1.15e-05	0.000187	CcSEcCtD
Emtricitabine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	1.14e-05	0.000185	CcSEcCtD
Emtricitabine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	1.13e-05	0.000184	CcSEcCtD
Emtricitabine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	1.13e-05	0.000184	CcSEcCtD
Emtricitabine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	1.12e-05	0.000182	CcSEcCtD
Emtricitabine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	1.12e-05	0.000182	CcSEcCtD
Emtricitabine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	1.11e-05	0.000181	CcSEcCtD
Emtricitabine—Rash—Efavirenz—acquired immunodeficiency syndrome	1.11e-05	0.000181	CcSEcCtD
Emtricitabine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	1.11e-05	0.000181	CcSEcCtD
Emtricitabine—Nausea—Indinavir—acquired immunodeficiency syndrome	1.11e-05	0.00018	CcSEcCtD
Emtricitabine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	1.1e-05	0.00018	CcSEcCtD
Emtricitabine—Headache—Efavirenz—acquired immunodeficiency syndrome	1.1e-05	0.00018	CcSEcCtD
Emtricitabine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	1.1e-05	0.000179	CcSEcCtD
Emtricitabine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	1.08e-05	0.000175	CcSEcCtD
Emtricitabine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	1.07e-05	0.000174	CcSEcCtD
Emtricitabine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	1.07e-05	0.000173	CcSEcCtD
Emtricitabine—Rash—Delavirdine—acquired immunodeficiency syndrome	1.06e-05	0.000173	CcSEcCtD
Emtricitabine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	1.06e-05	0.000173	CcSEcCtD
Emtricitabine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	1.06e-05	0.000173	CcSEcCtD
Emtricitabine—Headache—Delavirdine—acquired immunodeficiency syndrome	1.05e-05	0.000172	CcSEcCtD
Emtricitabine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	1.05e-05	0.000172	CcSEcCtD
Emtricitabine—Nausea—Efavirenz—acquired immunodeficiency syndrome	1.05e-05	0.00017	CcSEcCtD
Emtricitabine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	1.03e-05	0.000168	CcSEcCtD
Emtricitabine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	1.03e-05	0.000167	CcSEcCtD
Emtricitabine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	1.03e-05	0.000167	CcSEcCtD
Emtricitabine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	1.01e-05	0.000165	CcSEcCtD
Emtricitabine—Nausea—Delavirdine—acquired immunodeficiency syndrome	1e-05	0.000163	CcSEcCtD
Emtricitabine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	9.91e-06	0.000161	CcSEcCtD
Emtricitabine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	9.9e-06	0.000161	CcSEcCtD
Emtricitabine—Rash—Ritonavir—acquired immunodeficiency syndrome	9.82e-06	0.00016	CcSEcCtD
Emtricitabine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	9.81e-06	0.00016	CcSEcCtD
Emtricitabine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	9.78e-06	0.000159	CcSEcCtD
Emtricitabine—Headache—Ritonavir—acquired immunodeficiency syndrome	9.75e-06	0.000159	CcSEcCtD
Emtricitabine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	9.53e-06	0.000155	CcSEcCtD
Emtricitabine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	9.45e-06	0.000154	CcSEcCtD
Emtricitabine—Rash—Saquinavir—acquired immunodeficiency syndrome	9.45e-06	0.000154	CcSEcCtD
Emtricitabine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	9.44e-06	0.000154	CcSEcCtD
Emtricitabine—Headache—Saquinavir—acquired immunodeficiency syndrome	9.39e-06	0.000153	CcSEcCtD
Emtricitabine—Nausea—Ritonavir—acquired immunodeficiency syndrome	9.25e-06	0.000151	CcSEcCtD
Emtricitabine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	9.09e-06	0.000148	CcSEcCtD
Emtricitabine—Rash—Lamivudine—acquired immunodeficiency syndrome	9.01e-06	0.000147	CcSEcCtD
Emtricitabine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	9.01e-06	0.000147	CcSEcCtD
Emtricitabine—Headache—Lamivudine—acquired immunodeficiency syndrome	8.96e-06	0.000146	CcSEcCtD
Emtricitabine—Nausea—Saquinavir—acquired immunodeficiency syndrome	8.9e-06	0.000145	CcSEcCtD
Emtricitabine—Nausea—Lamivudine—acquired immunodeficiency syndrome	8.49e-06	0.000138	CcSEcCtD
